Drug news
FDA approves Stendra (Vivus Inc) for Erectile Dysfunction
The FDA has approved Stendra (avanafil) tablets, from Vivus Inc, for the treatment of Erectile Dysfunction (ED). The approval is based on a study of more than 1,200 men with ED which evaluated the efficacy and safety of Stendra. At all doses tested (50mg, 100mg and 200mg), the drug met all primary efficacy endpoints. Significant improvement in erectile function was also observed for all doses in Stendra-treated patients compared to placebo. Vivus Inc is currently in discussion with potential partners to commercialize Stendra in the US and in its territories in the rest of the world.